Clinical Trial Update: Study is to Assess the Safety and Tolerability of VTx-002 in Participants With ALS [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 clinical trial is planned to evaluate the safety and tolerability of VTx-002 in participants with amyotrophic lateral sclerosis, and is currently re…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Amyotrophic Lateral Sclerosis

Drugs mentioned

• VTx-002

Snippet

Sponsor: Vector Y Therapeutics | Conditions: Amyotrophic Lateral Sclerosis | Phase 1, Phase 2 | Status: RECRUITING